CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED) - USD ($) shares in Thousands, $ in Thousands	Total	Adoption of ASU 2016-13	After Adoption of ASU 2016-13	Common Stock	Common Stock After Adoption of ASU 2016-13	Additional Paid-In Capital	Additional Paid-In Capital After Adoption of ASU 2016-13	Accumulated Deficit	Accumulated Deficit Adoption of ASU 2016-13	Accumulated Deficit After Adoption of ASU 2016-13
Beginning Balance at Dec. 31, 2021	$ 103,908			$ 11,384		$ 105,511		$ (12,987)
Beginning Balance (in shares) at Dec. 31, 2021				15,622
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(5,027)							(5,027)
Vesting of restricted stock	(59)			$ (6)		(53)
Vesting of restricted stock (in shares)				153
Stock-based compensation expense	571			$ 57		514
Ending Balance at Mar. 31, 2022	99,393			$ 11,435		105,972		(18,014)
Ending Balance (in shares) at Mar. 31, 2022				15,775
Beginning Balance at Dec. 31, 2021	103,908			$ 11,384		105,511		(12,987)
Beginning Balance (in shares) at Dec. 31, 2021				15,622
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(3,901)
Ending Balance at Sep. 30, 2022	101,350			$ 11,518		106,720		(16,888)
Ending Balance (in shares) at Sep. 30, 2022				15,923
Beginning Balance at Mar. 31, 2022	99,393			$ 11,435		105,972		(18,014)
Beginning Balance (in shares) at Mar. 31, 2022				15,775
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	528							528
Vesting of restricted stock	(62)			$ (6)		(56)
Vesting of restricted stock (in shares)				148
Stock-based compensation expense	489			$ 49		440
Ending Balance at Jun. 30, 2022	100,348			$ 11,478		106,356		(17,486)
Ending Balance (in shares) at Jun. 30, 2022				15,923
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	598							598
Stock-based compensation expense	404			$ 40		364
Ending Balance at Sep. 30, 2022	101,350			$ 11,518		106,720		(16,888)
Ending Balance (in shares) at Sep. 30, 2022				15,923
Beginning Balance at Dec. 31, 2022	$ 102,624	$ (632)	$ 101,992	$ 11,591	$ 11,591	107,372	$ 107,372	(16,339)	$ (632)	$ (16,971)
Beginning Balance (in shares) at Dec. 31, 2022	15,973			15,973	15,973
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	$ 641							641
Vesting of restricted stock	(181)			$ (18)		(163)
Vesting of restricted stock (in shares)				82
Stock-based compensation expense	509			$ 51		458
Ending Balance at Mar. 31, 2023	102,961			$ 11,624		107,667		(16,330)
Ending Balance (in shares) at Mar. 31, 2023				16,055
Beginning Balance at Dec. 31, 2022	$ 102,624	$ (632)	$ 101,992	$ 11,591	$ 11,591	107,372	$ 107,372	(16,339)	$ (632)	$ (16,971)
Beginning Balance (in shares) at Dec. 31, 2022	15,973			15,973	15,973
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	$ (31,492)
Ending Balance at Sep. 30, 2023	$ 71,484			$ 11,690		108,257		(48,463)
Ending Balance (in shares) at Sep. 30, 2023	16,287			16,287
Beginning Balance at Mar. 31, 2023	$ 102,961			$ 11,624		107,667		(16,330)
Beginning Balance (in shares) at Mar. 31, 2023				16,055
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	1,102							1,102
Vesting of restricted stock	(301)			$ (30)		(271)
Vesting of restricted stock (in shares)				232
Stock-based compensation expense	444			$ 44		400
Ending Balance at Jun. 30, 2023	104,206			$ 11,638		107,796		(15,228)
Ending Balance (in shares) at Jun. 30, 2023				16,287
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(33,235)							(33,235)
Stock-based compensation expense	513			$ 52		461
Ending Balance at Sep. 30, 2023	$ 71,484			$ 11,690		$ 108,257		$ (48,463)
Ending Balance (in shares) at Sep. 30, 2023	16,287			16,287